In 2023, the FDA banned 19 peptides from compounding pharmacies. No specific safety incident. No clear signal. Just a regulatory decision that pushed millions of patients toward gray market suppliers and overseas Ipamorelin Peptide Dosing Guide: Timing, Protocol & Side Effects (2026) Rescheduling psilocybin and MDMA in Australia A process explainer The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Queensland Health Departmental Standard